Download presentation
Presentation is loading. Please wait.
Published byClifton Boone Modified over 9 years ago
1
Cancer Cx
2
Que-1 The most common gynecological malignancy in the world is – a) Vaginal Ca b) Cervical Ca c) Uterine Ca d) Ovarian Ca
3
Ans -1 b) Cervical Ca
4
Que-2 High risk type of HPV implicated in causation of Cx Ca a) HPV 6 & 11 b) HPV 11 & 16 c) HPV 16 & 18 d) HPV 22 & 45
5
Ans-2 c) HPV 16 & 18
6
Que-3 All the following are risk factor for development of Cervical Cancer EXCEPT a) Cigarette smoking b) Alcohol intake c) Intake of OCP d) HIV infection
7
Ans-3 b) Alcohol intake
8
Que-4 Primary sites of Lymphatic spread of cervical cancer are a) Presacral LN b) Ext & int iliac LN c) Common Iliac LN d) Para aortic LN
9
Ans-4 b) Ext & int iliac LN
10
Que-5 Mrs A has a growth on the Cx 2cm in size without any parametrial vaginal invasion. The treatment of choice would be a) Trachelectomy b) Pan Hysterectomy c) Wertheim’s Hysterectomy d) Conization
11
Ans-5 c) Wertheim’s Hysterectomy
12
Que-6 Complication of radiation therapy includes all EXCEPT a) Hematuria b) Diarrhoea c) Constipation d) Pelvic Pain
13
Ans-6 c) Constipation
14
Que-7 The most sensitive modality for post therapy surveillance for recurrent Cervical cancer is a) CT b) MRI c) Pap Smear d) PET-CT
15
Ans-7 d) PET-CT
16
Que-8 Thrombosis in patient with advanced cervical cancer is due to all except a) Impaired mobility b) Expression of pelvic veins by tumor mass c) Cancer related vascular factors d) Embolization of cancer cells
17
Ans-8 d) Embolization of cancer cells
18
Que-9 Conservative treatment of micro invasive lesions should only be considered when invasion is less than a) 1 mm b) 3mm c) 5mm d) 7mm
19
Ans-9 b) 3mm
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.